In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Point-of-care testing refers to diagnostic procedures conducted near the patient or at the site of care, outside of ...

Pricing pressure due to reimbursement cuts and limited budgets along with strict regulatory approval process for new point of care product commercialization are factors expected to restrain market ...

Changes in healthcare economics are clearly having an impact on point-of-care (POC) diagnostic testing. Market demand for remote testing is driving companies to develop easy-to-use platforms versus ...

The development of new tests to address new diseases, or those that previously had no useful biomarker, is stimulating IVD growth. It is interesting that many of these new analytes are almost ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

DUBLIN--(BUSINESS WIRE)--The "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...